Glass House Brands Inc. (GLASF)
OTCMKTS
· Delayed Price · Currency is USD
5.76
+0.94 (19.50%)
Jun 25, 2025, 3:58 PM EDT
Glass House Brands Revenue
Glass House Brands had revenue of $44.82M in the quarter ending March 31, 2025, with 48.90% growth. This brings the company's revenue in the last twelve months to $215.62M, up 31.97% year-over-year. In the year 2024, Glass House Brands had annual revenue of $200.90M with 24.91% growth.
Revenue (ttm)
215.62M
Revenue Growth
+31.97%
P/S Ratio
2.11
Revenue / Employee
619.59K
Employees
374
Market Cap
454.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Elite Pharmaceuticals | 70.00M |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
Glass House Brands News
- 1 day ago - Glass House Brands Inc. Announces Voting Results Following Annual and Special Meeting - GlobeNewsWire
- 7 days ago - 3 Top Marijuana Stocks For Your Summer Watchlist - MarijuanaStocks
- 22 days ago - Top U.S. Marijuana Stocks to Watch This Week Amid Legalization Momentum - MarijuanaStocks
- 5 weeks ago - Top Performing U.S. Marijuana Stocks to Watch in 2025 - MarijuanaStocks
- 5 weeks ago - Glass House Brands Announces Mailing of Circular and Establishment of Share-based Long-term Management Incentive Plan Pending Shareholder Approval - GlobeNewsWire
- 5 weeks ago - Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out - Benzinga
- 6 weeks ago - These Cannabis Stocks Could Pay Off Big In The Future - MarijuanaStocks
- 6 weeks ago - Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement - GlobeNewsWire